Breaking News, Collaborations & Alliances

GSK, OncoMed Form Cancer Collaboration

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline and OncoMed Pharmaceuticals have formed a strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells. These cells are believed to play a key role in the establishment, metastasis and recurrence of cancer. The alliance will be conducted through GSK’s Center of Excellence for External Drug Discovery (CEEDD). The alliance leverages OncoMed’s expertise in the discovery and development of cancer stem cell antibody therapeu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters